PLx Pharma Langfristiger Schuldenstrom 2011-2026 | PLXP

Langfristiger Schuldenstrom Jährlich PLx Pharma

2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	622 K	3.66 M	2.91 M	-	-	-	-	-	-	-

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
3.66 M	622 K	2.4 M

Langfristiger Schuldenstrom anderer Aktien in der Arzneimittelhersteller

Name	Langfristiger Schuldenstrom	Preis	% 24h	Marktkapitalisierung	Land
AcelRx Pharmaceuticals ACRX	5.36 M	-	7.5 %	$ 6.35 M	USA
Alimera Sciences ALIM	634 K	-	-	$ 142 M	USA
Aerie Pharmaceuticals AERI	4.36 M	-	-	$ 754 M	USA
Agile Therapeutics AGRX	366 K	-	10.11 %	$ 58.2 M	USA
Adamis Pharmaceuticals Corporation ADMP	343 K	-	0.86 %	$ 117 M	USA
Canopy Growth Corporation CGC	7.46 M	$ 0.97	2.36 %	$ 104 M	Canada
Aurora Cannabis ACB	5.38 M	$ 3.31	1.53 %	$ 86.3 M	Canada
China Pharma Holdings CPHI	39.3 K	$ 0.63	16.11 %	$ 11 M	China
Catalent CTLT	13 M	-	-	$ 11.5 B	USA
Athenex ATNX	2.09 M	-	-23.39 %	$ 1.76 M	USA
Avadel Pharmaceuticals plc AVDL	582 K	-	-	$ 2.06 B	France
DURECT Corporation DRRX	1.38 M	-	-	$ 50.1 M	USA
Emergent BioSolutions EBS	3.5 M	$ 8.05	-1.71 %	$ 412 M	USA
Endo International plc ENDP	956 K	-	-	$ 28.9 M	Irlanda
Evoke Pharma EVOK	13.4 K	-	-	$ 36.6 M	USA
Calliditas Therapeutics AB (publ) CALT	3.91 M	-	-0.1 %	$ 2.03 B	Schweden
HEXO Corp. HEXO	914 K	-	2.45 %	$ 38.1 M	Canada
Cumberland Pharmaceuticals CPIX	357 K	$ 3.05	7.77 %	$ 42.9 M	USA
Bausch Health Companies BHC	61 M	$ 5.1	1.8 %	$ 1.86 B	Canada
Harrow Health HROW	887 K	$ 34.0	2.16 %	$ 1.25 B	USA
Assertio Holdings ASRT	240 K	$ 14.0	4.71 %	$ 89.6 M	USA
OptiNose OPTN	911 K	-	-	$ 1.08 B	USA
Evolus EOLS	2.53 M	$ 4.68	0.86 %	$ 302 M	USA
Eagle Pharmaceuticals EGRX	1.53 M	-	-39.89 %	$ 27.7 M	USA
Pacira BioSciences PCRX	8.89 M	$ 22.65	2.44 %	$ 1.05 B	USA
OrganiGram Holdings OGI	1.03 M	$ 1.36	-	$ 402 M	Canada
PetIQ PETQ	7.61 M	-	1.64 %	$ 400 M	USA
ProPhase Labs PRPH	301 K	-	-	$ 5.07 M	USA
Jupiter Wellness JUPW	213 K	-	-	$ 33.6 M	USA
Radius Health RDUS	613 K	-	-	$ 1.42 B	USA
Rockwell Medical RMTI	1.38 M	$ 1.02	-2.86 %	$ 23.8 M	USA
Lannett Company LCI	2.06 M	-	1.15 %	$ 7.11 M	USA
Sundial Growers SNDL	35.5 M	$ 1.36	0.74 %	$ 3.37 M	Canada
SCYNEXIS SCYX	483 K	$ 0.88	-6.09 %	$ 43.9 M	USA
Solid Biosciences SLDB	2.1 M	$ 7.14	1.56 %	$ 625 M	USA
Organogenesis Holdings ORGO	4.27 M	$ 2.47	3.65 %	$ 325 M	USA
Neoleukin Therapeutics NLTX	2.56 M	-	-	$ 193 M	Canada
Perrigo Company plc PRGO	25.7 M	$ 9.57	3.46 %	$ 1.33 B	USA
Sonoma Pharmaceuticals SNOA	58 K	$ 2.55	4.94 %	$ 3.16 M	USA
Tilray TLRY	2.47 M	$ 6.45	3.86 %	$ 3.99 B	Canada
Recro Pharma REPH	1.1 M	-	-4.76 %	$ 65.3 M	USA
TherapeuticsMD TXMD	1.47 M	$ 2.31	3.12 %	$ 24.1 M	USA
Veru VERU	1.07 M	$ 2.3	1.32 %	$ 310 M	USA
Viatris VTRS	80.6 M	$ 13.29	0.68 %	$ 16 B	USA
cbdMD YCBD	98.7 K	$ 0.76	11.88 %	$ 3.28 M	USA
Tricida TCDA	2.74 M	-	-	$ 3.25 M	USA
Zynerba Pharmaceuticals ZYNE	215 K	-	-	$ 55.5 M	USA